[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345640-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345640-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","globo-h-diagnostic-stratification-and-identification-of-dusp14-as-a-candidate-target-in-colorectal-cancer","Globo-H diagnostic stratification and identification of DUSP14 as a candidate target in colorectal cancer","","Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, creating an urgent need for precise, personalized therapies. Globo-H is a glycan target with diagnostic and therapeutic relevance across multiple cancers. Using histology-based classification, patients were stratified into Globo-H-high and Globo-H-low groups, then RNA-sequencing defined signaling pathways linked to Globo-H overactivation. Among genes meeting the Globo-H histology criterion, DUSP14 emerged as an actionable pharmacological target associated with Globo-H abundance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/globo-h-diagnostic-stratification-and-identification-of-dusp14-as-a-candidate-target-in-colorectal-cancer/345640/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/globo-h-diagnostic-stratification-and-identification-of-dusp14-as-a-candidate-target-in-colorectal-cancer/345640.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How were colorectal cancer patients stratified in this study?","Question",{"text":63,"@type":64},"Patients were grouped into Globo-H-high and Globo-H-low categories using a histology-based classification.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What gene was identified as a candidate target related to Globo-H abundance?",{"text":68,"@type":64},"DUSP14 emerged as a promising, pharmacologically actionable target associated with Globo-H abundance.",{"name":70,"@type":61,"acceptedAnswer":71},"What effects did DUSP14 inhibition have?",{"text":72,"@type":64},"DUSP14 inhibition suppressed tumor growth and altered TAK1-MAPK signaling.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345640,1791450239,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","DOI: 10.1002/ijc.70461  \nRES EARCH A RTICLE  \nCancer Therapy a nd Prevention  \nGlobo-H diagnostic stratification and identification of DUSP14 as a candidate target in colorectal cancer  \nKeren Zohar 1 | Marco Strecker 2  | Thomas Wartmann 2 | Wenjie Shi 2 | Frederike Stelter 2 | Maximilian Doelling 2 | Mihailo Andric 2 | Or Kakhlon 3 | Christian Täger 4 | Denny Schanze 5 | Michael Linnebacher 6 |  \nMichael Naumann 4  | Daniel E. Stange 7 | Dörthe Jechorek 8 | Roland S. Croner 2,9 | Michal Linial 1  | Ulf D. Kahlert 2,9   \n1Department of Biological Chemistry, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel  \n2Molecular and Experimental Surgery, Department of General, Visceral, Vascular and Transplantation Surgery, Faculty of Medicine, Otto-von-Guericke-University, Magdeburg, Germany  \n3Department of Neurology, The Anges Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel  \n4Institute for Experimental Medicine, Faculty of Medicine, Otto-von-Guericke-University, Magdeburg, Germany 5Institute of Human Genetics, Faculty of Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany 6Department of Surgery, University Rostock Medical Center, Rostock, Germany  \n7Department of Visceral-, Thoracic-and Vascular-Surgery, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany  \n8Institute of Pathology, Faculty of Medicine, Otto-von-Guericke University, Magdeburg, Germany 9Research Campus Stimulate, Otto-von-Guericke University, Magdeburg, Germany  \nCorrespondence  \nMichal Linial, Department of Biological Chemistry, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.  \n[Email:](Email: michall@cc.huji.ac.il)[ michall@cc.huji.ac.il](Email: michall@cc.huji.ac.il)  \nUlf D. Kahlert, Molecular and Experimental Surgery, Department of General, Visceral, Vascular and Transplantation Surgery, Faculty of Medicine, Otto-von-Guericke-University, Magdeburg 39120, Germany.  \nEmail: [ulf.kahlert@med.ovgu.de](ulf.kahlert@med.ovgu.de)  \nAbstract  \nColorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, underscoring the urgent need for precise and personalized therapeutic strategies. Globo-H has emerged as a clinically relevant glycan target with promising diagnostic and therapeutic utility across multiple cancer types. In this study, we stratified colorectal cancer patients into Globo-H-high and Globo-H-low groups using a histology-based classification, followed by RNA-sequencing analyses to elucidate the key signaling pathways associated with Globo-H overactivation. Among the 31 genes that were identified to meet the Globo-H histology criterion, DUSP14 (dual specificity phosphatase 14) emerged as a promising pharmacological target associated with Globo-H abundance. DUSP14 is an underexplored but pharmacologically actionable therapeutic target. DUSP14 protein in colon cancer cells is inversely correlated with total  \nAbbreviations: ADC, antibody-drug conjugate; CI, confidence interval; COAD, colon adenocarcinoma; CRC, colorectal cancer; CSC, cancer stem cell; DEG, differentially expressed genes; GSL, glycosphingolipid; HR, hazard ratio; KM, Kaplan–Meier; OS, overall survival; PCA, principal component analysis; PDO, patient-derived organoid; PFS, progress free survival; PPI, protein–protein interaction; TACA, tumor-associated carbohydrate antigen.  \nKeren Zohar and Marco Strecker contributed equally to this study.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2026 The Author(s) . International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.  \nTransforming growth factor-β-activated kinase 1 (TAK1) protein. The druggability o","cbCaissWttwbP0T9","https://ap.wps.com/l/cbCaissWttwbP0T9","pdf",8891449,15,"English","# Abstract\n## Globo-H stratification and gene identification\n## DUSP14 targeting and functional validation\n## Implications for CRC theranostics","[{\"question\":\"How were colorectal cancer patients stratified in this study?\",\"answer\":\"Patients were grouped into Globo-H-high and Globo-H-low categories using a histology-based classification.\"},{\"question\":\"What gene was identified as a candidate target related to Globo-H abundance?\",\"answer\":\"DUSP14 emerged as a promising, pharmacologically actionable target associated with Globo-H abundance.\"},{\"question\":\"What effects did DUSP14 inhibition have?\",\"answer\":\"DUSP14 inhibition suppressed tumor growth and altered TAK1-MAPK signaling.\"}]","Globo-H diagnostic stratification and identification of DUSP14 as a candidate target in colorectal cancer | PDF",1790058422,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e6749583ec9810287319ada7d9d46c0.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0df7b0ac89dbcc20c851d33ad63a8ca2.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80adb31aa2e64b7c6f7aa12f982cc3ec.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34d27cb6f9f433d7fdf88066082f317f.webp",980,1287]